Stock Research for ESPR

ESPR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ESPR Stock Chart & Research Data

The ESPR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ESPR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ESPR Due diligence Resources & Stock Charts

The ESPR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ESPR Detailed Price Forecast - CNN Money CNN View ESPR Detailed Summary - Google Finance
Yahoo View ESPR Detailed Summary - Yahoo! Finance Zacks View ESPR Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ESPR Trends & Analysis - Trade-Ideas Barrons View ESPR Major Holders - Barrons
NASDAQ View ESPR Call Transcripts - NASDAQ Seeking View ESPR Breaking News & Analysis - Seeking Alpha
Spotlight View ESPR Annual Report - CompanySpotlight.com OTC Report View ESPR OTC Short Report - OTCShortReport.com
TradeKing View ESPR Fundamentals - TradeKing Charts View ESPR SEC Filings - Bar Chart
WSJ View Historical Prices for ESPR - The WSJ Morningstar View Performance/Total Return for ESPR - Morningstar
MarketWatch View the Analyst Estimates for ESPR - MarketWatch CNBC View the Earnings History for ESPR - CNBC
StockMarketWatch View the ESPR Earnings - StockMarketWatch MacroAxis View ESPR Buy or Sell Recommendations - MacroAxis
Bullish View the ESPR Bullish Patterns - American Bulls Short Pains View ESPR Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ESPR Stock Mentions - StockTwits PennyStocks View ESPR Stock Mentions - PennyStockTweets
Twitter View ESPR Stock Mentions - Twitter Invest Hub View ESPR Investment Forum News - Investor Hub
Yahoo View ESPR Stock Mentions - Yahoo! Message Board Seeking Alpha View ESPR Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ESPR - SECform4.com Insider Cow View Insider Transactions for ESPR - Insider Cow
CNBC View ESPR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ESPR - OTC Markets
Yahoo View Insider Transactions for ESPR - Yahoo! Finance NASDAQ View Institutional Holdings for ESPR - NASDAQ


Stock Charts

FinViz View ESPR Stock Insight & Charts - FinViz.com StockCharts View ESPR Investment Charts - StockCharts.com
BarChart View ESPR Stock Overview & Charts - BarChart Trading View View ESPR User Generated Charts - Trading View




Latest Financial News for ESPR


These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Posted on Thursday April 25, 2024

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.


Esperion to Report First Quarter 2024 Financial Results on May 7
Posted on Tuesday April 23, 2024

ANN ARBOR, Mich., April 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. Please click here to pre-register to participate in the conference call and obtain your dial in number and PIN. A live audio webcast can be accessed on the investor and me


11 Best Low Price Pharma Stocks To Invest In
Posted on Sunday April 21, 2024

In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]


Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
Posted on Sunday April 07, 2024

– Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared to Placebo – – NEXLETOL Demonstrated Clinical Benefit in Historically Underrepresented Groups: Women and Hispanic/Latinx Patients With and Without Cardiovascular Disease (CVD) – – CLEAR Outcomes Sets New Standards for Diversity and Inclusion with Enrollment of 48% Women and 17% Hispanic/Latinx Patients – ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion


Stock Market & Investing Books

Enter a stock symbol to view the stock details.